Live stream preview

Watch this video and more on armchairmedical.tv

Already subscribed? Sign in

The proportion of patients who reach the BMD surrogate threshold effect on romosozumab a post hoc analysis of the randomised FRAME and ARCH phase 3 trials Prof Jeffrey Hassall